Page last updated: 2024-11-11

mycoheptin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mycoheptin: Russian drug; from Streptoverticillium mycoheptinicum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6440819
MeSH IDM0052527

Synonyms (13)

Synonym
mycoheptin
antibiotic 44 vi
antibiotic 281471
mycoheptyne
amphotericin b, 5,8,9-trideoxy-7,10-dihydroxy-5-oxo-
m1wcp74lp5 ,
unii-m1wcp74lp5
12609-89-1
amphotericin b, 5,8,9-trideoxy-7,10-dihydroxy-5-oxo-, (7r,10r)-
(7r,10r)-5,8,9-trideoxy-7,10-dihydroxy-5-oxoamphotericin b
5-oxo-5-deoxy-28,29-didehydronystatin
(1s,3r,4r,7r,11r,15s,16r,17r,18s,19e,21e,23e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,11,17,37-heptahydroxy-15,16,18-trimethyl-9,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,
Q27283362

Research Excerpts

Effects

ExcerptReferenceRelevance
"Mycoheptin A1 has a lower biological activity and toxicity but its chemotherapeutic efficiency is higher."( [Physicochemical and biological characteristics of mycoheptin components A1 and A2].
Bershteĭn, EM; Bol'shakova, LO; Gagloshvili, VM; Mikhaĭlova, MA; Shenin, IuD, 1980
)
1.23
"Mycoheptin A1 has a lower biological activity and toxicity but its chemotherapeutic efficiency is higher."( [Physicochemical and biological characteristics of mycoheptin components A1 and A2].
Bershteĭn, EM; Bol'shakova, LO; Gagloshvili, VM; Mikhaĭlova, MA; Shenin, IuD, 1980
)
1.23

Actions

ExcerptReferenceRelevance
"Mycoheptin A1 has a lower biological activity and toxicity but its chemotherapeutic efficiency is higher."( [Physicochemical and biological characteristics of mycoheptin components A1 and A2].
Bershteĭn, EM; Bol'shakova, LO; Gagloshvili, VM; Mikhaĭlova, MA; Shenin, IuD, 1980
)
1.23
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (66.67)18.7374
1990's6 (28.57)18.2507
2000's0 (0.00)29.6817
2010's1 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]